Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex

被引:57
作者
Berrada, Zenda L. [1 ,3 ]
Lin, Shou-Yean Grace [1 ]
Rodwell, Timothy C. [2 ]
Duylinh Nguyen [1 ,4 ]
Schecter, Gisela F. [1 ]
Pham, Lucy [1 ]
Janda, J. Michael [1 ,5 ]
Elmaraachli, Wael [2 ]
Catanzaro, Antonino [2 ]
Desmond, Edward [1 ]
机构
[1] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] San Mateo Cty Dept, Hlth Publ Hlth Lab, San Mateo, CA USA
[4] Roche Mol Diagnost, Pleasanton, CA USA
[5] Kern Cty Hlth Dept, Publ Hlth Lab, Bakersfield, CA USA
关键词
Mycobacterium tuberculosis; multi-drug resistant tuberculosis; rifabutin; molecular drug-susceptibility; MULTICENTER LABORATORY VALIDATION; IN-VITRO ACTIVITY; CROSS-RESISTANCE; DRUG-RESISTANCE; MOLECULAR DIAGNOSIS; CLASSICAL; 2ND-LINE; RAPID DETECTION; STRAINS; SUSCEPTIBILITY; GENE;
D O I
10.1016/j.diagmicrobio.2016.01.019
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cross-resistance in rifamycins has been observed in rifampin (RIF)-resistant Mycobacterium tuberculosis complex isolates; some rpoB mutations do not confer broad in vitro rifamycin resistance. We examined 164 isolates, of which 102 were RIF-resistant, for differential resistance between RIF and rifabutin (RFB). A total of 42 unique single mutations or combinations of mutations were detected. The number of unique mutations identified exceeded that reported in any previous study. RFB and RIF MICs up to 8 mu g/mL by MGIT 960 were studied; the cut-off values for susceptibility to RIF and RFB were 1 mu g/mL and 0.5 mu g/mL, respectively. We identified 31 isolates resistant to RIF but susceptible to RFB with the mutations D516V, D516F, 518 deletion, S522L, H526A, H526C, H526G, H526L, and two dual mutations (S522L + K527R and H526S + K527R). Clinical investigations using RFB to treat multidrug-resistant tuberculosis cases harboring those mutations are recommended. (C) 2016 The Authors. Published by Elsevier Inc.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 40 条
[1]   Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency [J].
Anthony R.M. ;
Schuitema A.R.J. ;
Bergval I.L. ;
Brown T.J. ;
Oskam L. ;
Klatser P.R. .
Annals of Clinical Microbiology and Antimicrobials, 4 (1)
[2]   Rifamycins - Obstacles and opportunities [J].
Aristoff, Paul A. ;
Garcia, George A. ;
Kirchhoff, Paul D. ;
Showalter, H. D. Hollis .
TUBERCULOSIS, 2010, 90 (02) :94-118
[3]  
Barrera L., 2008, Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs
[4]   Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis [J].
Bernard, Christine ;
Veziris, Nicolas ;
Brossier, Florence ;
Sougakoff, Wladimir ;
Jarlier, Vincent ;
Robert, Jerome ;
Aubry, Alexandra .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) :1524-1529
[5]   MUTATION POSITION AND TYPE OF SUBSTITUTION IN THE BETA-SUBUNIT OF THE RNA-POLYMERASE INFLUENCE IN-VITRO ACTIVITY OF RIFAMYCINS IN RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS [J].
BODMER, T ;
ZURCHER, G ;
IMBODEN, P ;
TELENTI, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) :345-348
[6]   In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations [J].
Cavusoglu, C ;
Karaca-Derici, Y ;
Bilgic, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) :662-665
[7]   Molecular Detection of Rifabutin-Susceptible Mycobacterium tuberculosis [J].
Chen, Huang-Yao ;
Yu, Ming-Chih ;
Huang, Wei-Lun ;
Wu, Mei-Hua ;
Chang, Yung-Lin ;
Che, Chien-Rai ;
Jou, Ruwen .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (06) :2085-2088
[8]   Rifabutin for treating pulmonary tuberculosis [J].
Davies, G. ;
Cerri, S. ;
Richeldi, L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[9]   Strong In Vitro Activities of Two New Rifabutin Analogs against Multidrug-Resistant Mycobacterium tuberculosis [J].
Garcia, Ana-Belen ;
Palacios, Juan J. ;
Ruiz, Maria-Jesus ;
Barluenga, Jose ;
Aznar, Fernando ;
Cabal, Maria-Paz ;
Maria Garcia, Jose ;
Diaz, Natalia .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) :5363-5365
[10]   THE SERUM RIFABUTIN CONCENTRATIONS IN A PATIENT SUCCESSFULLY TREATED FOR MULTIRESISTANT MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
GILLESPIE, SH ;
BASKERVILLE, AJ ;
DAVIDSON, RN ;
FELMINGHAM, D ;
BRYCESON, ADM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) :490-491